NASDAQ
Kezar Life Sciences, Inc. (KZR) has a free cash flow growth of 37.76% as of Friday, May 29, 2026. This represents a 505.73% increase compared to its 12-month average of 6.23%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.